tiprankstipranks
Trending News
More News >
Transmedics Group (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Financial Statements

Compare
1,751 Followers

TransMedics Group Financial Overview

TransMedics Group's market cap is currently $4.98B. The company's EPS TTM is $2.62; its P/E ratio is 29.91; TransMedics Group is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is $0.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 605.49M$ 441.54M$ 241.62M$ 93.46M$ 30.26M
Gross Profit$ 362.81M$ 262.08M$ 154.09M$ 65.27M$ 21.16M
Operating Income$ 108.58M$ 37.50M$ -28.73M$ -31.44M$ -39.43M
EBITDA$ 148.49M$ 69.95M$ -7.70M$ -28.96M$ -38.49M
Net Income$ 190.29M$ 35.46M$ -25.03M$ -36.23M$ -44.22M
Balance Sheet
Cash & Short-Term Investments$ 488.37M$ 336.65M$ 394.81M$ 201.18M$ 92.45M
Total Assets$ 1.07B$ 804.08M$ 706.05M$ 277.15M$ 134.89M
Total Debt$ 469.69M$ 518.29M$ 515.95M$ 67.56M$ 43.80M
Net Debt$ -18.68M$ 181.64M$ 121.13M$ -133.63M$ 18.22M
Total Liabilities$ 595.27M$ 575.47M$ 568.85M$ 89.77M$ 67.04M
Stockholders' Equity$ 473.10M$ 228.60M$ 137.20M$ 187.38M$ 67.85M
Cash Flow
Free Cash Flow$ 133.59M$ -80.94M$ -192.09M$ -57.72M$ -32.38M
Operating Cash Flow$ 192.84M$ 48.80M$ -13.03M$ -45.82M$ -28.86M
Investing Cash Flow$ -59.25M$ -129.30M$ -193.95M$ 54.51M$ 29.27M
Financing Cash Flow$ 16.86M$ 22.87M$ 400.42M$ 167.93M$ 1.39M
Currency in USD

TransMedics Group Earnings and Revenue History

TransMedics Group Debt to Assets

TransMedics Group Cash Flow

TransMedics Group Forecast EPS vs Actual EPS